July 8, 2020 / 2:40 PM / a month ago

BRIEF-Smiths Detection Partners With Attomarker To Develop Triple Antibody Testing Device For Covid-19

July 8 (Reuters) - Smiths Group PLC:

* SMITHS DETECTION ANNOUNCES PARTNERSHIP WITH ATTOMARKER IN THE DEVELOPMENT OF A TRIPLE ANTIBODY TESTING DEVICE FOR COVID-19

* SMITHS DETECTION - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) HAS ALREADY APPROVED ATTOMARKER’S TRIPLE ANTIBODY TEST FOR NHS USE IN UK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below